We are live on ! Find out more
CYTXW

Cytori Therapeutics Inc Warrant
CYTXW

Delisted

CYTXW was delisted on the 14th of December, 2018.

Back to rankings

4 hedge funds and large institutions have $11K invested in Cytori Therapeutics Inc Warrant in 2017 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 1

20% less funds holding

Funds holding: 5 → 4 (-1)

76% less capital invested

Capital invested by funds: $46K → $11K (-$35K)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 1

Holders
4
Holders Change
-1
Holders Change %
-20%
% of All Funds
0.09%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
1
Reduced
1
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
VF
Virtu Financial
New York
+$159

Top Sellers

Rank Fund Capital Flow
1
SM
Sabby Management
Florida
-$5.57K
Name Holding Trade Value Shares
Change 		Change in
Stake
SM
1
Sabby Management
Florida
$11K -$5.57K -209,318 -17%
VF
2
Virtu Financial
New York
– +$159 +5,989 +57%

CYTXW Hedge Fund Activity: Q4 2017 in Review

4 of the 4,409 institutional investors tracked by Wall St. Rank reported a position in Cytori Therapeutics Inc Warrant (CYTXW) for Q4 2017, worth a combined $11K — down 76% from $46K a quarter earlier.

Sellers outnumbered buyers: 1 fund closed out of CYTXW and 0 opened new positions — a net loss of 1 holder — while 1 trimmed existing stakes and 1 added.

The largest buyer was Virtu Financial, adding an estimated $159. The largest seller was Sabby Management, cutting an estimated $5.57K.

  • 4 institutional investors held Cytori Therapeutics Inc Warrant (CYTXW) as of Q4 2017, down from 5 in Q3 2017.
  • Funds reported $11K of Cytori Therapeutics Inc Warrant stock for Q4 2017, down 76% quarter-over-quarter.
  • 0 funds opened new Cytori Therapeutics Inc Warrant positions in Q4 2017 and 1 closed out, a net change of -1 holder.
  • The largest Cytori Therapeutics Inc Warrant buyer in Q4 2017 was Virtu Financial, an estimated $159 added.
  • The largest Cytori Therapeutics Inc Warrant seller in Q4 2017 was Sabby Management, an estimated $5.57K sold.

Based on aggregated 13F filings for Q4 2017.